Full text is available at the source.
Abstract
The interpretation of therapeutic alliance's role in psilocybin treatment for treatment-resistant depression may not be adequately supported by the reported results.
- The conclusion that therapeutic alliance did not significantly impact treatment efficacy is questioned due to methodological concerns.
- Observed associations suggest that therapeutic alliance may influence both the psychedelic experience and clinical outcomes.
- Methodological weaknesses in the analysis could obscure relevant effects related to therapeutic alliance.
- Deviations from the study protocol were noted, indicating potential issues that require further investigation.
- Accurate characterization of psychological and contextual factors is essential in psychedelic treatment research.
Simplified